Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/17/24 16:14 | 4/4/24 | SRZN | Health | BioPrd | Biological Products, (No Diag | Column Group III Gp, LP | CA | T | 2 | P.d | 6,000 | 15.50 | 0 | 387 | 161 | 628 | I | |||||||||||||||
4/17/24 16:10 | 4/4/24 | SRZN | Health | BioPrd | Biological Products, (No Diag | Kutzkey Tim | CA | DT | 2 | P.d | 6,000 | 15.50 | 0 | 387 | 161 | 628 | I | |||||||||||||||
4/8/24 17:30 | 4/4/24 | SRZN | Health | BioPrd | Biological Products, (No Diag | Williams Charles O | CA | O | CFO,COO | 1 | P.d | 0 | 0.00 | 0 | 1 | 1 | D | |||||||||||||||
4/8/24 17:27 | 4/4/24 | SRZN | Health | BioPrd | Biological Products, (No Diag | Parker Craig C | CA | DO | CEO | 1 | P.d | 0 | 0.00 | 0 | 1 | 1 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |